Intact Therapeutics
Intact Therapeutics, based in Palo Alto and Los Altos, CA, specializes in developing smart gels for local drug delivery aimed at improving gastrointestinal disorder treatments.
Company Overview
Intact Therapeutics is a healthcare company based in Palo Alto, CA, and Los Altos, CA, USA. Founded in November 2018, it specializes in developing smart gels for local drug delivery to the gut, aiming to improve the treatment of gastrointestinal disorders. The company participated in Y Combinator's Winter 2019 (W19) batch and operates in the United States of America as well as offering remote and partly remote services.
Services
Intact Therapeutics focuses on the development of smart gels designed for local drug delivery to the gut. This technology aims to enhance the treatment options for various gastrointestinal disorders. By targeting drug delivery locally, the company seeks to improve therapeutic outcomes and patient experiences.
Industry and Sub-Industry
Intact Therapeutics operates within the healthcare industry, specifically in the therapeutics sub-sector. The company's core objective is to develop innovative treatments for gastrointestinal disorders using advanced drug delivery systems.
Key Partnerships
Intact Therapeutics has established partnerships with several prominent organizations. These include Encube Ethicals, Y Combinator, Stanford University, Brightstone Venture Capital, and the UCSF Rosenman Institute. These collaborations provide support and resources crucial to the company's development and operational goals.
Regional Operations
Intact Therapeutics operates primarily in the United States of America, with a presence in the broader America/Canada region. The company offers remote and partly remote services, making its innovative healthcare solutions accessible to a wider range of patients and healthcare providers.